SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001062993-14-004546
Filing Date
2014-08-05
Accepted
2014-08-05 16:43:26
Documents
4
Period of Report
2014-08-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 12109
2 EXHIBIT 10.1 exhibit10-1.htm EX-10.1 43386
3 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 7415
4 GRAPHIC logo.jpg GRAPHIC 5171
  Complete submission text file 0001062993-14-004546.txt   71349
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34236 | Film No.: 141016697
SIC: 2834 Pharmaceutical Preparations